Medscape www.medscape.com

References for:
Bronchiolitis Obliterans Organizing Pneumonia Mimicking Community-Acquired Pneumonia

[J Am Board Fam Pract 11(1):41-45, 1998. © 1998 American Board of Family Practice]

  1. Epler GR, Colby TV, McLoud TC, Carrington CB, Gaensler EA. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985;312:152-8.
  2. Chandler PW, Shin MS, Friedman SE, Myers JL, Katzenstein AL. Radiographic manifestations of bronchiolitis obliterans with organizing pneumonia vs usual interstitial pneumonia. AJR Am J Roentgenol 1986;147:899-906.
  3. Cordier JF, Loire R, Brune J. Idiopathic bronchiolitis obliterans organizing pneumonia. Definition of characteristic clinical profiles in a series of 16 patients. Chest 1989;96:999-1004.
  4. Epler GR. Bronchiolitis obliterans organizing pneumonia: definition and clinical features. Chest 1992;
    102 (1 Suppl):2S-6S.
  5. King TE Jr, Mortenson RL. Cryptogenic organizing pneumonitis: The North American experience. Chest 1992;102(1 Suppl):8S-13S.
  6. Costabel U, Teschler H, Schoenfeld B, Hartung W, Nusch A, Guzman J, et al. BOOP in Europe. Chest 1992;102(1 Suppl):14S-20S.
  7. Yamamoto M, Ina Y, Kitaichi M, Harasawa M, Tamura M. Clinical features of BOOP in Japan. Chest 1992;102(1 Suppl):21S-5S.
  8. Nagai S, Aung H, Tanaka S, Satake N, Mio T, Kawatani A, et al. Bronchoalveolar lavage cell findings in patients with BOOP and related diseases. Chest 1992;102(1 Suppl):32S-7S.
  9. Cohen AJ, King TE Jr, Downey GP. Rapidly progressive bronchiolitis obliterans with organizing pneumonia. Am J Respir Crit Care Med 1994;149:
    1670-5.
  10. Alasaly K, Muller N, Ostrow DN, Champion P, FitzGerald JM. Cryptogenic organizing pneumonia. A report of 25 cases and a review of the literature. Medicine (Baltimore) 1995;74:201-11.
  11. Nishimura K, Itoh H. High-resolution computed tomographic features of bronchiolitis obliterans organizing pneumonia. Chest 1992;102(1 Suppl):26S-31S.
  12. Costabel U, Guzman J, Teschler H. Bronchiolitis obliterans with organising pneumonia: outcome. Thorax 1995;50(Suppl 1):S59-S64.
  13. Schwarz MI, Matthay RA, Sahn SA, Stanford RE, Marmorstein BL, Scheinhorn DJ. Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature. Medicine (Baltimore) 1976;55:89-104.
  14. Yousem SA, Colby TV, Carrington CB. Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis 1985;
    131:770-7.
  15. Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990;141:727-33.
  16. Matteson EL, Ike RW. Bronchiolitis obliterans organizing pneumonia and Sjögren's syndrome. J Rheumatol 1990;17:676-9.
  17. Patel RC, Dutta D, Schonfeld SA. Free-base cocaine use associated with bronchiolitis obliterans organizing pneumonia. Ann Intern Med 1987;107:186-7.
  18. Camus P, Lombard JN, Perrichon M, Piard F, Guerin JC, Thivolet FB, et al. Bronchiolitis obliterans organizing pneumonia in patients taking acebutolol or amiodarone. Thorax 1989;44:711-5.
  19. Santrach PJ, Askin FB, Wells RJ, Azizkhan RG, Merten DF. Nodular form of bleomycin-related pulmonary injury in patients with osteogenic sarcoma. Cancer 1989;64:806-11.
  20. Allen JN, Wewers MD. HIV-associated bronchiolitis obliterans organizing pneumonia. Chest 1989;
    96:197-8.
  21. Kuwano K, Hayashi S, MacKenzie A, Hogg JC. Detection of adenovirus DNA in paraffin-embedded lung tissues from patients with bronchiolitis obliterans and organizing pneumonia (BOOP) using in situ hybridization. Am Rev Respir Dis 1990;141:A319.
  22. Sepuya SM, Grzybowski S, Burton JD, Clement JG. Diffuse lung changes associated with gold therapy. Can Med Assoc J 1978;118:816-8.
  23. Heyd J, Simmeran A. Gold-induced lung diseases. Postgrad Med J 1983;59:368-70.
  24. Morley TF, Komansky HJ, Adelizzi RA, Giudice JC. Pulmonary gold toxicity. Eur J Respir Dis 1984;65:
    627-32.
  25. Dreis DF, Winterbauer FH, Van Norman GA, Sullivan SL, Hammar SP. Cephalosporin-induced interstitial pneumonitis. Chest 1984;86:138-40.
  26. Takimoto CH, Lynch D, Stulbarg MS. Pulmonary infiltrates associated with sulindac therapy. Chest 1990;97:230-2.
  27. Camp M, Mehta JB, Whitson M. Bronchiolitis obliterans and Nocardia asteroides infection of the lung. Chest 1987;92:1107-8.
  28. McCormick J, Cole S, Lahirir B, Knauft F, Cohen S, Yoshida T. Pneumonitis caused by gold salt therapy: evidence for the role of cell-mediated immunity in its pathogenesis. Am Rev Respir Dis 1980;122:145-52.
  29. Peramaki E, Salmi I, Kava T, Romppanen T, Hakkarainen T. Unilateral bronchiolitis obliterans organizing pneumonia and bronchoalveolar lavage neutrophilia in a patient with parainfluenza 3 virus infection. Respir Med 1991;85:159-61.
  30. Corrin B. Bronchiolitis obliterans organizing pneumonia. A British view. Chest 1992;102(1 Suppl):7S.
  31. Lynch JP 3d, Sitrin RG. Noninfectious mimics of community-acquired pneumonia. Semin Respir Infect 1993;8:14-45.
  32. Colby TV. Pathologic aspects of bronchiolitis obliterans organizing pneumonia. Chest 1992;102(1 Suppl):38S-43S.
  33. Izumi T. Introduction (International Congress on BOOP). Chest 1992;102(1 Suppl):1S.
  34. Izumi T. Congress summary (International Congress on BOOP). Chest 1992;102(1 Suppl):50S.
  35. Ezri T, Kunichezky S, Eliraz A, Soroker D, Halperin D, Schattner A. Bronchiolitis obliterans--current concepts. Q J Med 1994;87:1-10.
  36. Kitaichi M. Differential diagnosis of bronchiolitis obliterans organizing pneumonia. Chest 1992;102(1 Suppl):44S-9S.